Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.3.2.19 (
ubiquitin-protein ligase
)
799
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The KCNQ1 K(+) channel plays a key role in the regulation of several physiological functions, including cardiac excitability, cardiovascular tone, and body electrolyte homeostasis. The metabolic sensor
AMP-activated protein kinase
(
AMPK
) has been shown to regulate a growing number of ion transport proteins. To determine whether
AMPK
regulates KCNQ1, we studied the effects of
AMPK
activation on KCNQ1 currents in Xenopus laevis oocytes and collecting duct epithelial cells.
AMPK
activation decreased KCNQ1 currents and channel surface expression in X. laevis oocytes, but
AMPK
did not phosphorylate KCNQ1 in vitro, suggesting an indirect regulatory mechanism. As it has been recently shown that the
ubiquitin-protein ligase
Nedd4-2 inhibits KCNQ1 plasma membrane expression and that
AMPK
regulates epithelial Na(+) channels via Nedd4-2, we examined the role of Nedd4-2 in the
AMPK
-dependent regulation of KCNQ1. Channel inhibition by
AMPK
was blocked in oocytes coexpressing either a dominant-negative or constitutively active Nedd4-2 mutant, or a Nedd4-2 interaction-deficient KCNQ1 mutant, suggesting that Nedd4-2 participates in the regulation of KCNQ1 by
AMPK
. KCNQ1 is expressed at the basolateral membrane in mouse polarized kidney cortical collecting duct (mpkCCD(c14)) cells and in rat kidney. Treatment with the
AMPK
activators AICAR (2 mM) or metformin (1 mM) reduced basolateral KCNQ1 currents in apically permeabilized polarized mpkCCD(c14) cells. Moreover, AICAR treatment of rat kidney slices ex vivo induced
AMPK
activation and intracellular redistribution of KCNQ1 from the basolateral membrane in collecting duct principal cells. AICAR treatment also induced increased ubiquitination of KCNQ1 immunoprecipitated from kidney slice homogenates. These results indicate that
AMPK
inhibits KCNQ1 activity by promoting Nedd4-2-dependent channel ubiquitination and retrieval from the plasma membrane.
...
PMID:AMP-activated protein kinase inhibits KCNQ1 channels through regulation of the ubiquitin ligase Nedd4-2 in renal epithelial cells. 2086 Oct 72